Book a free demo with us
Book Now

MNDL Bio

MNDL Bio is a Synthetic Biology startup aiming to reduce cost and production time of food and biotech applications through advanced computational platforms that optimize gene expression.

Total Fundraised$5B

PE Round
Late Stage
Debt Financing
Pre-IPO
Series C
Series B
Series A
Others
Calendar Image2023
Established
HeadquarterGradient ImageTel Aviv, Israel
Headquarter
OperationalGradient Image
ISR
Operational Market
SectorGradient Image
Biotechnology
Biotech
Genetic
Bioinformatics
Primary Sector
EmployeeGradient Image -
Employees
GlobeGradient Imagehttps://www.mndl.bio/
Website

Funding Types by Funds Raised (in USD)

Content Locked

Login or Register a FREE account to continue browsing our content

Cumulative Funding Raised Over Time

Content Locked

Login or Register a FREE account to continue browsing our content

MNDL Bio's Investors by Funding Rounds

Funding Round

Announced Date

Disclosed Investors

Round Amount (USD)

Content Locked

Login or Register a FREE account to continue browsing our content